文献速递甲状腺与颈部外科

分子表达谱术前预测分化型甲状腺癌侵袭性病理特征的验证

Validation of molecular profiling to preoperatively predict aggressive pathologic features in differentiated thyroid cancer.
PubMed 文献 · Surgery · 2025-10-06

本研究纳入2017至2024年接受Afirma基因组测序分类器检测并手术的445例甲状腺结节患者,按ATA指南分为低危366例和中/高危79例,评估30种分子特征与风险分层的关联。

要点

  • Invasion Score可术前预测更高ATA风险分类,或辅助决定手术范围。
  • NIS表达升高与较低ATA风险分类相关,可能提示保护作用。
  • 30种特征中23种在ATA风险组间表达差异显著。

核心结论

  • 多种分子特征表达谱在ATA风险分类间差异显著,可能增强术前预后判断。
  • Invasion Score反映更高风险病理特征,NIS表达上调似乎降低高ATA风险分类几率。

研究设计与样本

  • 回顾性队列研究,纳入2017至2024年接受Afirma基因组测序分类器检测并手术的445例甲状腺结节患者。
  • 按手术病理ATA指南分为低危366例和中/高危79例,比较30种分子特征表达。
  • 采用Mann-Whitney U检验、Kruskal-Wallis检验及逻辑回归多因素分析。

主要发现

  • 30种特征中23种(77%)在ATA风险组间表达差异显著。

关键数值与推荐

  • Invasion Score用于排除甲状腺外侵犯或广泛血管侵犯。
  • NIS表达反映甲状腺碘摄取相关跨膜糖蛋白的mRNA水平。
  • ATA风险分类基于手术病理特征。

临床怎么用

  • 术前分子检测或可辅助识别适合腺叶切除的低危患者,避免不必要的全切。
  • Invasion Score高或NIS表达低的患者可能需更积极手术范围,但需进一步验证。

局限性

  • NIS表达的保护作用需进一步研究确认。
  • 回顾性设计,样本来自单一检测方法人群。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The 2015 American Thyroid Association guidelines stratify recurrence risk of differentiated thyroid cancer using pathologic findings. Aggressive features may reclassify tumors as intermediate-to-high risk in patients initially suitable for lobectomy, warranting completion thyroidectomy. Signatures represent distinct patterns of mRNA expression on the basis of molecular pathway features. This study evaluated whether molecular expression profiles ("signatures") could preoperatively differentiate high-risk tumors and potentially guide extent of surgery. METHODS: Patients who underwent thyroid nodule molecular testing with the Afirma Genomic Sequencing Classifier and subsequent operative resection from 2017 to 2024 were identified. Using features described on surgical pathology, patients were grouped into ATA guideline-based low-risk or intermediate/high-risk cohorts. Among the signatures assessed, Invasion Score was developed to rule out extrathyroidal extension or extensive vascular invasion, whereas Sodium-Iodide Symporter Expression reflects mRNA production levels of the transmembrane glycoprotein involved in thyroid-iodine uptake. Signatures were compared among cohorts using Mann-Whitney U and Kruskal-Wallis tests. Logistic regression was used for multivariate analysis. RESULTS: Of 445 patients analyzed, 366 were low risk and 79 were intermediate/high risk. Among 30 signatures evaluated, expression varied significantly among study cohorts in 23 (77%). Multivariate analysis demonstrated the Invasion Score signature as predictive of greater American Thyroid Association risk classification (odds ratio, 1.3; 95% confidence interval, 1.1-1.5, P = .005) whereas Sodium-Iodide Symporter Expression was protective (odds ratio, 0.78; 95% confidence interval, 0.63-0.94, P = .015). CONCLUSION: Multiple signature expression profiles showed marked variation among American Thyroid Association risk classes and may help enhance preoperative prognostication. Although Invasion Score mirrors greater risk pathologic features, upregulated Sodium-Iodide Symporter Expression appears to protect from greater American Thyroid Association risk class, although further studies are needed to confirm.

来源:Surgery,查看原文。版权归原作者所有。

引用

  1. Bauzon J, Shin J, Plitt G, et al. Validation of molecular profiling to preoperatively predict aggressive pathologic features in differentiated thyroid cancer. Surgery. 2025. PMID: 41058325. doi:10.1016/j.surg.2025.109698

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。